// App-Quantinova.ai

115P : Evaluation of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs)

Researchers

Presenter

  • A.Prawira

Principal Investigators

  • P.Dufort

  • J.Halankar

  • D.M.Paravasthu

  • A.Spreafico

  • A.R.Hansen

  • A.R.Abdul Razak

  • P.L.Bedard

  • M.Butler

  • S.Lheureux

  • A.M.Oza

  • R.W.Jang

  • K.M.Suta

  • S.Boross-Harmer

  • J.Cipollone

  • H.Chow

  • U.Metser

  • L.L.Siu

Medical Centers

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Medical Image Analysis, Tomographix IP, Toronto, ON, Canada

  • Joint Department of Medical Imaging, University of Toronto Health Network, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved